Furthermore, immunoblotting demonstrated that PTPRO was enriched in exosomes derived from PTPRO overexpressing cells, indicating that PTPRO could be encapsulated in exosomes delivered from breast cancer cells (Figure 3C). The gene discussed is PTPRO; the disease is breast carcinoma.